4//SEC Filing
Deardorf Caren 4
Accession 0000899243-21-027882
CIK 0001690585other
Filed
Jul 7, 8:00 PM ET
Accepted
Jul 8, 4:33 PM ET
Size
5.5 KB
Accession
0000899243-21-027882
Insider Transaction Report
Form 4
Deardorf Caren
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-07-06+200,000→ 200,000 totalExercise: $9.41Exp: 2031-07-05→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exerciseable over four years, with 25% of this option vesting on July 6, 2022, and the remainder vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Magenta Therapeutics, Inc.
CIK 0001690585
Entity typeother
Related Parties
1- filerCIK 0001871152
Filing Metadata
- Form type
- 4
- Filed
- Jul 7, 8:00 PM ET
- Accepted
- Jul 8, 4:33 PM ET
- Size
- 5.5 KB